Discrepant findings in immune responses to JC virus in patients receiving natalizumab

The Lancet Neurology

Volumn 9, Issue 6, 2010, Pages 565-566

  Tan, Chen S ^a   Chen, Yiping ^a   Viscidi, Raphael P ^b   Kinkel, R Philip ^a   Stein, Marion C ^a   Koralnik, Igor J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; DNA; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NATALIZUMAB; VIRUS ANTIBODY;

ANTIBODY DETECTION; BLOOD ANALYSIS; CELLULAR IMMUNITY; CYTOMEGALOVIRUS; DNA EXTRACTION; ENZYME LINKED IMMUNOSPOT ASSAY; EPSTEIN BARR VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; JC VIRUS; LETTER; METHODOLOGY; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; T LYMPHOCYTE; TREATMENT OUTCOME; URINALYSIS;

ANTIBODIES, MONOCLONAL; ANTIGENS; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-BETA; JC VIRUS; MULTIPLE SCLEROSIS; T-LYMPHOCYTES;

EID: 77952317127     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70124-1     Document Type: Letter

References (7)

1. Jilek S., Jaquiery E., Hirsch H.H., et al. Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study. Lancet Neurol 9 (2010) 264-272
2. Ransohoff R.M. PML risk and natalizumab: more questions than answers. Lancet Neurol 9 (2010) 231-233
3. Chen Y., Bord E., Tompkins T., et al. Asymptomatic reactivation of JC virus in patients treated with natalizumab. N Engl J Med 361 (2009) 1067-1074
4. Gorelik L., Bixler S., Lerner M., et al. Evaluation of the incidence of anti-JCV antibodies in a cohort of natalizumab-treated MS patients. Neurology 74 suppl 2 (2010) A390
5. Du Pasquier R.A., Schmitz J.E., Jean-Jacques J., et al. Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals. J Virol 78 (2004) 10206-10210
6. Du Pasquier R.A., Kuroda M.J., Zheng Y., Jean-Jacques J., Letvin N.L., and Koralnik I.J. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 127 (2004) 1970-1978
7. Biogen Idec Medical Information Service. April 2010 (accessed April 6, 2010).